Purpose of the company: Contract research for the pharmaceutical industry, as well as the production, administration, utilization, and marketing of "Extract Rheum rhaponticum 731," abbreviated as "ERr731Âź," and other pharmaceutical products domestically and internationally.
Adress: HofÀckerstr. 14 76698 Ubstadt-Weiher Deutschland
Local court: 68159 Mannheim
Register number: HRB704699
The average total assets of company Health Research Services GmbH over the last 13 years is 866.771,54 âŹ.
The company Health Research Services GmbH as of the reporting date 2022 a bank balance of approx. 0,00 âŹ. That is -100,00 % less than the average bank balance in the industry of companies with this total assets.
The equity ratio of Health Research Services GmbH is -17,31 % in the year 2022. In total, that ist -154.370,00 âŹ.
The average absolute change in liquidity of the company Health Research Services GmbH compared to the previous year amounts to -59.408,25 âŹ. That means that the liquidity of the company has increased or decreased by this amount per year on average.
The cash flow of the company Health Research Services GmbH amounts to -712.899,00 ⏠in the year 2022.
The publication dates refer to the date on which the company published its annual financial statements in the company register. This information can provide important insights into the management of the company.
The information presented here comes from publicly accessible sources, in particular the Unternehmensregister, in which companies are obliged to disclose their annual financial statements (Sections 325 et seq. of the German Commercial Code (HGB)).
All key financial figures are based on the companies' published annual financial statements. The information is analysed automatically by Bonscore, without content processing or interpretation.
Please note that despite the utmost care, no guarantee can be given that the information provided is up-to-date, complete or correct.